Nan, Y., Wang, K., Hu, M., Luo, Q., Wu, X., Yu, X., Zhou, X., Chen, L., Li, B., Cui, Z., Liu, Z. (2026). Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer. Nature Communications. https://doi.org/10.1038/s41467-026-70001-5